Men on apalutamide therapy for nmCRPC who took metformin or ACE inhibitors concomitantly had longer metastasis-free survival compared with those who did not.
Startup news and updates: Daily roundup (May 16, 2024) yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival.
PSA Levels Post-Treatment May Not Predict Prostate Cancer Survival miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.